The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis
- 28 September 2014
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 47 (1) , 117-130
Abstract
Hyperlipidaemia has been identified as a risk factor for diabetic nephropathy via exacerbation of glomerular injury through the activation of multiple signaling pathways. This study’s aim is to assess the associations between polymorphisms of genes involved in lipid metabolism, such as apolipoprotein E (ApoE), peroxisome proliferator-activated receptor γ (PPARγ), acetyl-CoA carboxylase β (ACACB), and type 2 diabetic nephropathy (T2DN). A search of the MEDLINE and Web of Science databases was used to identify relevant studies, and allele or genotype frequencies were pooled using fixed- or random-effects models. Forty-five studies were included in this meta-analysis, consisting of 10,920 type 2 diabetic patients with nephropathy and 16,203 type 2 diabetic patients without nephropathy. The OR for ApoE ε2 versus ε3 was 1.49 (95 % CI 1.13–1.95) in T2DN. The progression of T2DN was related to the presence of the ε2 allele and ε2 carrier with ORs of 1.72 (95 % CI 1.10–2.69) and 1.78 (95 % CI 1.18–2.69), respectively. The rs1801282 C>G variant in PPARγ presented a significant association with decreased T2DN risk, both in the G allele and GC/GG genotype with ORs of 0.77 (95 % CI 0.68–0.87) and 0.79 (95 % CI 0.69–0.92), respectively. The T allele in rs2268388 within ACACB showed an increased risk for T2DN, exhibiting an OR of 1.35 (95 % CI 1.12–1.63). Our meta-analysis supports that the ApoE ε2 allele and ACACB rs2268388 C>T might act as promotion factors of nephropathy in type 2 diabetes, whereas PPARγ rs1801282 C>G is a promising candidate genetic variation for reducing susceptibility to T2DN.Keywords
This publication has 51 references indexed in Scilit:
- Role of the ACE ID and PPARG P12A Polymorphisms in Genetic Susceptibility of Diabetic Nephropathy in a South Indian PopulationNephro-Urology Monthly, 2013
- Peroxisome Proliferator–Activated Receptor γ Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 DiabetesDiabetes Care, 2012
- The Effect of ACACB cis-Variants on Gene Expression and Metabolic TraitsPLOS ONE, 2011
- Genetic associations in diabetic nephropathy: a meta-analysisDiabetologia, 2010
- The acetyl-coenzyme A carboxylase beta (ACACB) gene is associated with nephropathy in Chinese patients with type 2 diabetesNephrology Dialysis Transplantation, 2010
- A Single Nucleotide Polymorphism within the Acetyl-Coenzyme A Carboxylase Beta Gene Is Associated with Proteinuria in Patients with Type 2 DiabetesPLOS Genetics, 2010
- Pro12Ala Polymorphism in thePPARGGene Contributes to the Development of Diabetic Nephropathy in Chinese Type 2 Diabetic PatientsDiabetes Care, 2009
- Impact of the PPAR-γ2 Pro12Ala Polymorphism and ACE Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: Evidence From BENEDICTDiabetes, 2009
- Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPAR and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetesNephrology Dialysis Transplantation, 2009
- Measuring inconsistency in meta-analysesBMJ, 2003